Skip to main content
JYNT logo

The Joint Corp.

JYNTNASDAQHealthcareMedical Care Facilities

$7.28Today:- (-)1Y −10.09%

As of Oct 26, 2026 close

Market cap
$103.72M
P/E (TTM)
27.31
Forward P/E
14.23
Dividend yield
-
52-week range
$6.79$10.67
Volume (live)
-
Avg. volume (3M)
81.11K

The Joint (JYNT) Cash Flow Statement

In fiscal 2025 (fiscal year ended Dec 31, 2025), The Joint generated $1.84M of operating cash flow and spent $1.50M on capital expenditures. That left free cash flow of $334.72K, down 95.9% from $8.23M a year earlier, or 0.6% of revenue. It repurchased $11.32M of its own shares.

The Joint Cash Flow Statement Analysis

Values in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for The Joint Corp. (JYNT) - Annual data in millions USD
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017
Period endingDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017
Operating Activities
Net Income2.91-5.80-9.750.637.5713.173.320.25-3.28
Depreciation & Amortization1.714.728.586.653.922.731.901.562.02
Deferred Income Tax0.09-0.0610.90-0.44-1.780.000.00-0.080.02
Stock Based Compensation1.301.681.741.271.060.890.720.630.59
Change in Working Capital-9.561.160.80-0.243.662.551.602.780.38
Change in Accounts Receivable1.53-1.650.19-0.15-1.640.79-1.84-0.08-0.12
Change in Inventory0.000.000.000.000.000.003.391.11-0.72
Change in Accounts Payable-0.390.07-1.380.82-0.01-0.090.080.06-0.04
Change in Other Working Capital-5.14-3.31-0.220.54-0.87-0.36-0.031.681.26
Other Operating Activities5.487.71-0.22-0.10-1.79-8.15-0.020.310.42
Net Cash from Operating Activities1.849.4214.688.2113.8411.187.525.450.16
Investing Activities
Capital Expenditures-1.50-1.19-5.00-5.90-6.99-3.16-4.17-1.39-0.45
Acquisitions7.780.55-1.19-12.11-5.77-0.53-3.12-0.100.00
Sales/Maturities of Investments0.000.000.000.000.00-1.040.000.000.00
Other Investing Activities0.000.000.000.110.000.130.150.250.08
Net Cash from Investing Activities6.27-0.63-6.19-17.90-12.75-4.60-7.14-1.24-0.37
Financing Activities
Debt Repayment0.00-2.00-0.02-0.05-2.81-0.06-1.120.000.77
Common Stock Issued1.520.030.200.381.521.010.000.330.29
Common Stock Repurchased-11.32-0.010.00-0.01-0.71-0.03-0.020.000.00
Other Financing Activities0.00-0.030.00-0.05-0.083.740.550.330.36
Net Cash from Financing Activities-9.81-2.000.170.33-2.005.60-0.600.331.42
Summary
Net Change in Cash-1.696.788.66-9.36-0.9112.18-0.214.531.21
Cash at Beginning of Period26.0019.2110.5519.9120.828.648.854.323.01
Cash at End of Period24.3026.0019.2110.5519.9120.828.648.854.22
Free Cash Flow0.338.239.682.316.858.033.364.06-0.29
Supplemental Disclosures
Interest Paid-0.070.170.070.070.04---
Income Taxes Paid-0.610.57-0.370.570.24---

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About The Joint Cash Flow

What is The Joint's free cash flow?

The Joint generated free cash flow of $334.72K in fiscal 2025 (fiscal year ended Dec 31, 2025), operating cash flow of $1.84M minus $1.50M of capital expenditures. That was down 95.9% from $8.23M a year earlier. Free cash flow equaled 0.6% of revenue.

How much does The Joint spend on capital expenditures?

The Joint spent $1.50M on capital expenditures in fiscal 2025, compared with $1.19M a year earlier. That equals 81.8% of operating cash flow.

Does The Joint pay dividends or buy back shares?

Yes. In fiscal 2025 The Joint returned $11.32M in share buybacks to shareholders, according to its cash flow statement.

What is free cash flow?

Free cash flow is operating cash flow minus capital expenditures. It is the cash a company has left for dividends, buybacks, debt repayment or acquisitions after funding its operations and investment. Full definition